Literature DB >> 8053891

Alteration of intracellular Ca2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia.

S Treves1, F Larini, P Menegazzi, T H Steinberg, M Koval, B Vilsen, J P Andersen, F Zorzato.   

Abstract

Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalational anaesthetics and skeletal-muscle relaxants, appears to be due to an alteration of intracellular Ca2+ homoeostasis. MH occurs in 1 out of 20,000 anaesthetized adults and is characterized by hypermetabolism, skeletal-muscle rigidity and elevation in body temperature, which is frequently fatal [MacLennan and Phillips (1992) Science 256, 789-794]. The defect responsible for the disease may lie within the mechanism controlling the release of Ca2+ from sarcoplasmic reticulum via the ryanodine-receptor (RYR) Ca2+ channel; in fact a point mutation in the RYR has been associated with MH in some human families, as well as in the MH-susceptible pig. To date, however, no direct evidence has been obtained demonstrating that the point mutation is both necessary and sufficient to cause functional alterations in RYR-mediated Ca2+ release. In the present report we show that the presence of the Arg-to-Cys point mutation in the recombinant RYR expressed in COS-7 transfected cells causes abnormal cytosolic Ca2+ transients in response to 4-chloro-m-cresol, an agent capable of eliciting in vitro contracture of MH-susceptible muscles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053891      PMCID: PMC1137039          DOI: 10.1042/bj3010661

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

Review 1.  Incorporation of macromolecules into living cells.

Authors:  P L Mcneil
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Inositol 1,4,5-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine.

Authors:  P S Foster; E Gesini; C Claudianos; K C Hopkinson; M A Denborough
Journal:  Lancet       Date:  1989-07-15       Impact factor: 79.321

4.  Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia.

Authors:  J R Mickelson; E M Gallant; L A Litterer; K M Johnson; W E Rempel; C F Louis
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia.

Authors:  J M Ervasti; M T Claessens; J R Mickelson; C F Louis
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

7.  Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin.

Authors:  V M Samokyszyn; D M Miller; D W Reif; S D Aust
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

8.  Localization of Ca2+ release channels with ryanodine in junctional terminal cisternae of sarcoplasmic reticulum of fast skeletal muscle.

Authors:  S Fleischer; E M Ogunbunmi; M C Dixon; E A Fleer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Suxamethonium chloride and malignant hyperpyrexia.

Authors:  G J Galloway; M A Denborough
Journal:  Br J Anaesth       Date:  1986-04       Impact factor: 9.166

10.  Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release.

Authors:  F Zorzato; E Scutari; V Tegazzin; E Clementi; S Treves
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

View more
  11 in total

1.  Central core disease mutations R4892W, I4897T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ release.

Authors:  Guo Guang Du; Vijay K Khanna; Xinghua Guo; David H MacLennan
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

Review 2.  Genetic analysis of voltage-dependent calcium channels.

Authors:  C F Fletcher; N G Copeland; N A Jenkins
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

3.  Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2001-09       Impact factor: 4.086

Review 4.  Ryanodine receptor channelopathies.

Authors:  Matthew J Betzenhauser; Andrew R Marks
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

5.  Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.

Authors:  K Censier; A Urwyler; F Zorzato; S Treves
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Single-channel properties of the recombinant skeletal muscle Ca2+ release channel (ryanodine receptor).

Authors:  S R Chen; P Leong; J P Imredy; C Bartlett; L Zhang; D H MacLennan
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

7.  Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia.

Authors:  Dawei Jiang; Wenqian Chen; Jianmin Xiao; Ruiwu Wang; Huihui Kong; Peter P Jones; Lin Zhang; Bradley Fruen; S R Wayne Chen
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

Review 8.  Malignant hyperthermia.

Authors:  Henry Rosenberg; Mark Davis; Danielle James; Neil Pollock; Kathryn Stowell
Journal:  Orphanet J Rare Dis       Date:  2007-04-24       Impact factor: 4.123

9.  The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.

Authors:  Guillermo Avila; Kristen M S O'Connell; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2003-03-17       Impact factor: 4.086

10.  Variable myopathic presentation in a single family with novel skeletal RYR1 mutation.

Authors:  Ruben Attali; Sharon Aharoni; Susan Treves; Ori Rokach; Michal Becker Cohen; Yakov Fellig; Rachel Straussberg; Talya Dor; Muhannad Daana; Stella Mitrani-Rosenbaum; Yoram Nevo
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.